FDA continues battle against large animal antiparasitic resistanceJanuary 2, 2020With 2020 underway, the U.S. Food and Drug Administration (FDA) says it is continuing its ongoing effort to address issues related to antiparasitic resistance in livestock and horses across the country.
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More